Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. The Company operates its businesses through three segments. The Non-clinical Drug Research Service segment mainly provides non-clinical drug safety evaluation services, pharmacodynamic research services, and pharmacokinetic research services. The Clinical Services and Others segment mainly provides pre-market clinical services and pharmacovigilance services for drugs. The Experimental Model Supply segment is responsible for the production and sales of experimental models and their ancillary products. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in HKD (TTM)2.08bn
- Net income in HKD344.76m
- Incorporated1998
- Employees2.55k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869582
- Websitehttps://www.joinnlabs.com/
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Singapore) Ltd.as of 02 Oct 2025 | 6.82m | 5.73% |
| Fidelity Management & Research Co. LLCas of 03 Oct 2025 | 5.82m | 4.89% |
| UBS Asset Management (Hong Kong) Ltd.as of 09 Oct 2024 | 5.45m | 4.58% |
| E Fund Management Co., Ltd.as of 24 Apr 2025 | 5.01m | 4.21% |
| FIL Investment Management (Hong Kong) Ltd.as of 02 Oct 2025 | 4.46m | 3.75% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 3.94m | 3.31% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 3.80m | 3.19% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.86m | 1.56% |
| Huashang Fund Management Co., Ltd.as of 30 Jun 2025 | 1.21m | 1.01% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 1.15m | 0.96% |
